UPC Analytics
DEEN
Übersicht · Eingereicht: 19. Nov. 2025

UPC_CFI_693/2025

A SYSTEM FOR NEUROMODULATION

Einstweilige MaßnahmenEinstweilige MaßnahmenMunich LDProvisional measuresCase Closed
Zusammenfassung in einfacher Sprache

ONWARD Medical sought a preliminary injunction against Niche Biomedical (ANEUVO) for infringement of EP 3 421 081 B1, a spinal cord stimulation system patent. The Munich Local Division denied the PI because ONWARD filed auxiliary requests with amended claims, which the court treated as an implicit concession that the granted patent was likely invalid. The court also rejected both the main injunction application and Niche Biomedical's request for EUR 168,000 interim cost reimbursement due to wholly unsubstantiated cost submissions.

Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • Patent likely invalid in granted form given patentee's own auxiliary requests

    BeklagterRechtsgrundlage: Art. 62 UPCA; Leitsatz 2 of the order

    Hinweis: Court held that filing auxiliary requests with amended claims constitutes an implicit admission that the granted claim version is probably not valid, making a PI on the granted claims untenable.

Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Auxiliary requests for provisional measures based on amended claim versions should be admitted

    KlägerRechtsgrundlage: Art. 62 UPCA; Leitsatz 1 of the order

    Begründung: Court established as a headnote that auxiliary requests seeking provisional measures based on claim versions deviating from the granted patent are as a rule inadmissible; the PI procedure is confined to the granted claim text.

  • Preliminary cost reimbursement of EUR 168,000 should be granted to respondent

    BeklagterRechtsgrundlage: R. 211.1(d); R. 151(e); R. 152.1 VerfO

    Begründung: Court found the cost submissions entirely unsubstantiated and internally inconsistent (different law firms claimed EUR 80k and EUR 135k for nearly identical briefs), making any estimate impossible.